Dietary Iron Overview

Switch to mobile view »

To ensure that you get the iron your body needs, it's important that your diet include foods that are rich in iron.

Eating Heme vs. Non-Heme Iron

There are two types of iron: heme and non-heme iron.

  • Heme Iron — This form of iron comes from animal sources, such as red meat, and makes up about 10% of the dietary iron most people ingest.1 Heme iron is more easily absorbed.2
  • Non-heme Iron — Non-heme iron comes from a variety of other sources, making up the remaining 90% of dietary iron. Non-heme iron is more difficult for the body to absorb. Absorption is facilitated by ascorbic acid, or other sugars and acids that help increase the iron's solubility.2

Challenges in Non-Heme Iron Absorption

Getting the right amount of iron isn't just about eating iron-rich foods; it can also mean eating them in the right combination. Certain foods can also increase or decrease the amount of non-heme iron your body absorbs.

Important Safety Information

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

Warning

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

Precautions

Administration of Drug
  • General: Take 2 hours after meals. Do not exceed recommended dose. Discontinue use if symptoms of intolerance appear. The type of anemia and underlying cause or causes should be determined before starting therapy with Ferralet® 90 tablets. Ensure Hgb, Hct, reticulocyte count are determined before starting therapy and periodically thereafter during prolonged treatment. Periodically review therapy to determine if it needs to be continued without change or if a dose change is indicated. This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
  • Folic Acid: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using these products since folic acid may mask the symptoms of pernicious anemia.
  • Pediatric Use: Safety and effectiveness in pediatric patients have not been established.
  • Geriatric Use: Dosing for elderly patients should be cautious. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range.

This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.

Please see full Prescribing Information

  1. Barton JC. Iron deficiency. In Rakel RE, Bope ET. Conn's Current Therapy, 2008. Amsterdam, The Netherlands: Saunders/Elsevier, 385-389.
  2. Iron. Taber's Cyclopedic Medical Dictionary - Ed. 20, Editor Donald Venes. F.A. Davis Company 2005